News & Events
-
October 5, 2023
European Association of the Study of Diabetes Annual Meeting, C-Path T1D Consortium Presentation and Reception
Join C-Path staff as we explore groundbreaking discussions on Immunotherapy and Beta Cell Preservation in Type 1 Diabetes, taking us from clinical trials to clinical practice. Session 59 – Immunotherapy and Beta Cell Preservation in Type 1 Diabetes Oct 5 | 2 PM CEST | Spotlight Stage Agenda: Click Here EASD Register: Visit EASD Reception Details: Peering into...... -
October 3, 2023
C-Path Rare and Orphan Disease Conference Highlights Unprecedented Collaborations and Breakthroughs in Rare Disease Research
TUCSON, Ariz., October. 3, 2023 — The Critical Path Institute (C-Path) held its highly anticipated Rare and Orphan Disease Conference in September, bringing together leading experts, pharmaceutical industry leaders, regulatory agencies, and patient advocates to explore the latest advancements in rare disease research and drug development. The three-day conference, held at the Marriott Metro Center...... -
September 28, 2023 - September 29, 2023
Complex In Vitro Model: Qualification Framework Public Workshop
The Critical Path Institute’s Predictive Safety Testing Consortium is excited to announce a public workshop to improve complex in vitro model (CIVM) development with stakeholders from the U.S. Food and Drug Administration, academia, model developers and the pharmaceutical industry. Sept. 28-29, 2023 | The Bethesdan Hotel – Bethesda, MD Attendees will meet to form a...... -
September 20, 2023
The CPP Consortium Welcomes Biohaven as its Newest Member
The Critical Path for Parkinson’s Consortium is excited to welcome Biohaven as its newest member. Biohaven is a biopharmaceutical company aimed at discovering and developing novel life-changing therapies for people living with neurological and neuropsychiatric diseases by collaborating with leaders in scientific discovery and medicine. CPP is excited to work with Biohaven as one of many new members from...... -
September 18, 2023
C-Path and EATRIS Join Forces with New Collaboration Agreement
AMSTERDAM and TUCSON, Ariz., September 18, 2023 — Critical Path Institute (C-Path) and EATRIS (the European Research Infrastructure for Translational Medicine) are pleased to announce the signing of a collaboration agreement aimed at fostering actionable scientific and educational cooperation. This agreement marks a significant milestone in the pursuit of patient-centric innovation and the advancement of......